CARDIAC INVOLVEMENT IN IRON DEFICIENCY ANEMIA

View at publisher Summarise with VIRAT
Authors: Gülberat Totur, Özlem Üzüm
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Growth hormone plays a crucial role in systemic homeostasis, exerting anabolic, metabolic, and cardioprotective effects. Growth hormone deficiency, the most common pituitary hormone deficiency, not only impairs somatic growth in children but also leads to significant cardiovascular and metabolic disturbances in both pediatric and adult populations. Structural cardiac changes in growth hormone deficiency include reduced left ventricular mass, end-diastolic diameter, and stroke volume, which can be partially reversed with growth hormeone replacement therapy. Functional abnormalities, such as impaired systolic and diastolic functions, decreased exercise capacity, and altered myocardial performance indices, are commonly observed in growth hormone deficiency and may persist despite treatment.Advanced imaging methods such as cardiac magnetic resonans imaging have revealed biventricular remodeling and decreased cardiac volumes in untreated growth hormone deficiency. While growth hormone replacement therapy improves cardiac output and maximal oxygen uptake, full normalization is rarely achieved. Furthermore, changes in electrocardiography parameters and evidence of cardiac autonomic dysfunction suggest that long-term growth hormone deficiency may contribute to arrhythmogenic risk and increased cardiovascular mortality. Growth hormone/ insulin like growth factor-1 axis also supports vascular health by promoting nitric oxide synthesis, enhancing endothelial function, and reducing arterial stiffness.Emerging studies indicate that growth hormone-releasing hormone and its analogs offer cardioprotective benefits independent of the growth hormone/ insulin like growth factor-1 axis, including enhanced contractility, reduced inflammation, and reversal of myocardial fibrosis. These findings underscore the importance of cardiovascular monitoring in growth hormone deficiency and support the therapeutic potential of both growth hormone and growth hormone releasing hormone-based interventions in mitigating cardiac risks. Incorporating cardiovascular evaluation into the routine management of growth hormone deficiency patients may improve long-term outcomes and quality of life.Keywords: Cardiac remodeling; Cardiovascular risk; Electrocardiograph; Exercise capasity;Growth hormone deficiency; Growth hormone replacement therapy

Fields of Study & Subjects

Growth Hormone and Insulin-like Growth Factors Hormonal and reproductive studies Cardiovascular Function and Risk Factors

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
309–316
Publication date
1 January 2026
Language
EN
Document type
Book chapter